 |
MyScoop Media Inc
Contact: Amy Lemley Bailey
Telephone: 205-222-8494
E-mail: amy@myscoop.us
Website: http://www.myscoop.us
|
| |
|
| |
Industry/Market Size:
My Scoop reaches over 500,500 monthly viewers. We recently launched Nashville, are looking to launch Jackson by the end of the year and will add one more city during 2010. If we can do 4 cities successfully then we would look at a major expansion covering 16 markets.
|
| |
|
| |
Company Description:
After 7 years in magazine publishing and always wanting to publish a style magazine geared towards the Southeast, it became evident that with the way the world was going I needed to do this online. My Scoop started out as a blog and became a webzine in December 2007. MyScoop www.myscoop.us targets the Southern woman ages 22-40 which was an untapped market by the media in Birmingham and still remains untapped in cities throughout the Southeast. My Scoop is the only strictly online style magazine in the Southeast. MyScoop's revenue is generated through online advertising, email advertising, event sponsorships, and a VIP membership card 'The Scoopette Club Card'.
|
| |
|
| |
Value Proposition:
With women making the buying decisions whether it is on a new pair of shoes or new home, and with women ages 22-40 being the trendsetters in today's society, it is not just important but necessary for companies to tap into this market and realize how vital they are to our economy. My Scoop connects with these individuals through sophisticated, educational, yet fun and entertaining information. Previously this market was not being reached by local and regional media. My Scoop has cultivated an audience that is both loyal and responsive to My Scoop editorial, My Scoop promotions, and My Scoop events.
|
| |
|
 |
PhotonRx LLC
Contact: Bill Hart
Telephone: 205-862-0560
Email: bhart@photonrx.net
|
| |
Industry:
Therapeutic medical cold laser for human and vet markets
Human market - $800 mil – orthopedic, pain management, healing
Vet market - $100 mil – orthopedic, trauma, wound care
|
| |
|
| |
Company Description:
PhotonRx plans to sell and further research the Ig2000 cold laser for use in veterinarian and human applications related to advanced healing through immune system modulation. Our goal is to further veterinarian sales and obtain FDA clearance for human sales while developing new models for different human applications.
|
| |
|
| |
Value Proposition:
The Ig2000 light therapy initiates an immune system response via the modulation of Nitric Oxide, a cellular communicator. Ig2000 treatments reduce: healing time, inflammation, pain, scarring, and increase range of motion. Applications are in: orthopedic, physical rehab, general surgery, neurology and internal medicine. The Ig2000 acts as an “initiator” or “starter” to the immune system to via the production/modulation of Nitric Oxide. The light therapy is classified by the FDA as: Non-significant risk, a-thermal (no heat), and eye safe (can be used for the treatment of eye conditions.) Ig2000 treatments can be stand alone or in conjunction with drug therapy.
|
| |
|
| |
Financing Sought:
$1.25- 1.5 million - sales, operations, FDA and research
|
| |
|
| July 2009 |
|
| |
|
| |
Innovative Composite Solutions
Contact: Brian Pillay
Telephone: 205-999-0291
E-mail: pillay@innovativecompositesolutions.com
Website: http://www.innovativecompositesolutions.com
|
| |
|
| |
Industry/Market Size:
The current market value of thermoplastic composites is $4.8 billion (2008), mostly long fiber thermoplastics (ICS focus). Conservative market share projections/revenue for ICS is approximately $297.4 million/year after 5 years. New government and environmental initiatives for lightweight, recyclable and energy efficient components will accelerate demand creating tremendous potential for ICS |
| |
|
| |
Company Description:
ICS specializes in the design, development and manufacture of high end thermoplastic composite components for the military, aerospace, mass transit, energy, infrastructure and other high demand industry sectors. The company, in partnership with UAB, has developed a process that can convert components, initially built from metals to lighter weight, higher strength and lower cost fiber reinforced engineered plastics, that can be shaped and molded to exacting criteria and then produced at either high or low volumes. ICS provides turnkey solutions for the replacement of metal components and structures in applications that demand improved specific strength and superior performance. |
| |
|
| |
Value Proposition:
ICS is a technologically driven company that provides cutting edge solutions by adopting high end thermoplastic composite component applications. The company prides itself as a leader in providing innovative technology solutions, quality manufacturing and customer satisfaction.
ICS will provide shareholders an attractive return on equity through the following services offered by the company:
- Engineering design and prototyping (in partnership with UAB);
- Manufacturing and process optimization;
- Extrusion-compression manufacturing of thermoplastic composite materials;
- Injection molding specializing in thermoplastic composite materials, and
- Materials testing (in partnership with UAB).
|
| |
|
 |
Vista Engineering
Contact: Dr. Raymond Thompson
Telephone: 205-307-6550
Email: rthompson@vistaeng.com
Website: www.vistaeng.com
|
| |
|
| |
Industries Served: |
| |
Biomedical Implants: Vista coats the articulating joints of implants with diamond. First target market:
Jaw joint (TMJ) annual market: $15,000,000
Cutting Tools: Vista coats the cutting surface of the tools that have the toughest cutting challenges. The tools are made of tungsten carbide and coated by Vista with diamond for increased life. Targeted markets:
Mills, inserts, drills annual market: $500,000,000 |
| |
|
| |
Company Description: |
| |
Vista is a Birmingham, Alabama based Delaware C-corp. founded by Dr. R. G. Thompson in 1998. Vista’s mission is to commercialize diamond coating technology developed by UAB. These remarkable diamond coatings solve a difficult technology problem; a coating of superior hardness, toughness, and smoothness at an affordable price.
Funded with cash flow from R/D services ($200,000) and SBIR/STTR (NSF, NIH) grants (1,800,000), Vista’s first venture capital ($300,000) came from the Harbor Group in St. Louis. The company is currently funded by NIH to develop diamond coatings for TMJ prosthetics.
Vista has developed cutting tool inserts and drills which are moving toward marketing acceptance. |
| |
|
| |
Value Proposition: |
| |
Vista’s strategic international plan is to develop nanostructured diamond coatings as a core technology that is central to a platform of technologies that includes Cutting Tools, Biomaterials, Thin Film Windows, MEMS, and Sensors. Product lines will be developed from the vertical technologies of this platform. The products will be marketed and sold establishing a strong sales base. The business line will be strengthened with patented technologies. Each vertical technology will be sold as a stand alone business, leaving the core technology in Vista. |
| |
|
| |
Amount of Financing Sought: |
| |
Level appropriate for market segment that is targeted. |
| |
|
| May 2009 |
|
| |
|
 |
Community Entrepreneurship Institute
Contact: Dr. Karen Starks
Telephone: 205-915-3775
E-mail: kstarks@mindspring.com
Website: www.communityentrepreneurshipinstitute.org
|
| |
|
| |
Company Description:
Community Entrepreneurship Institute, Inc. is a 501(c) 3 non-profit organization dedicated to advancing social and economic well-being in urban communities through entrepreneurship. CEI, Inc. was developed with the philosophy that sustainable urban districts can best be created when entrepreneurs have a strong commitment to the customers and communities where they operate businesses.
|
| |
|
| |
Value Proposition:
CEI, Inc. seeks to train urban teens and residents to create businesses based on the product and service needs of their communities. The establishment of such non-profit and for-profit ventures creates sustainable urban areas with locally owned and operated businesses that provide employment opportunities to community residents.
|
| March 2009 |
|
| |
|
 |
MOTUS
1500 First Avenue North
Suite R115
Birmingham, AL 35203
Contact: Lee Conn
telephone: 205-314-3410
email: lee@motusmotorcycles.com
website: www.motusmotorcycles.com
|
| |
|
| |
Industry/ Market Size:
According to the Motorcycle Industry Council, over 815,000 streetbikes were sold domestically in 2008, down 4% from 2007. The $25 billion US market is well established with 13,000 dealerships, countless publications, and a huge aftermarket. Larger manufacturers, such as Harley Davidson (with 25% market share) have been declining while smaller, niche OEM's have shown stability and growth. |
| |
|
| |
Company Description:
MOTUS is developing a premium brand to offer the first American sport touring motorcycle. Neglected by other US manufacturers, sport touring is a profitable segment for European and Asian importers. MOTUS has negotiated very favorable and exclusive contracts with high profile, Detroit-based vendors who are diversifying into the huge motorcycle space. MOTUS VP, Brian Case, is an award-winning motorcycle designer and MOTUS President Lee Conn is a serial entrepeneur with experience in successful start-ups. |
| |
|
| |
Value Proposition:
MOTUS will provide shareholders an attractive return on equity by offering a premium bike with a proprietary engine and an industry leading design into a huge, existing space. The economic downturn is the exact lever needed to dramatically reduce R&D costs, shorten time to revenue, and prepare MOTUS to meet pent-up demand as the economy recovers in 24-36 months. |
| |
|
| |
Amount of Financing Sought:
$900,000 of additional capital through private offering to accredited investors only.
|
| |
|
| January 2009 |
|
| |
|
 |
Acuitec LLC
Primary Contact: Lionel Tehini
Telephone: (205) 266-0848
E-mail: ltehini@acuitec.com
Web Site: www.acuitec.com |
| |
|
| |
Industry/Market Size:
Healthcare IT and Services. Over 60 million surgical procedures performed each year in USA alone; over $9 billion dollars per year in treatment of hospital acquired disease.
|
| |
|
| |
Company Description:
Acuitec provides clinical solutions to High-Acuity Care facilities. Their flagship products are VPIMS (Perioperative Informatics Solution) and the award winning Vigilance (Remote Patient Management). These products were developed over several years in conjunction with Vanderbilt Medical Center where today they manage over 50,000 surgical procedures annually across 7 different facilities. The Vigilance solution has expanded into ICU patient monitoring and care, and is being deployed into other areas of care across the hospital. Vigilance has won numerous awards including being recognized by Microsoft user group as the most innovative product for healthcare and more recently by Intel.
|
| |
|
| |
Value Proposition:
- Improves patient care
- Optimizes OR efficiency and throughput
- Enhances patient safety and compliance
- Eliminates waste while reducing overall OR operational cost
- Improves clinical efficiency and outcomes
- Increases clinician efficiency and best use of their time
- Decreases post surgical infection and hospital acquired disease
- Early stage infection diagnosis significantly decreases costs
Optimizes billing/revenue
|
| |
|
| |
|
| |
|
| |
|
